SCHEMBL3033775

SCHEMBL3033775

O=C1NCc2c(Cl)ccc(-c3cc4ccccc4[nH]3)c21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.63
AURKA O14965 5/20 0.63
CDK1 P06493 1/20 0.49
CHEK1 O14757 1/20 0.48
CLK1 P49759 1/20 0.42
CLK2 P49760 1/20 0.42
CLK3 P49761 1/20 0.42
RAB9A P51151 3/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3046155 0.85 AURKA (0.65) KDRAURKACDK1CHEK1PRKCA
SCHEMBL3040225 0.84 AURKA (0.49) KDRAURKACDK1CHEK1CLK1
Hydrochloric Acid SCHEMBL3050705 0.83 AURKA (0.48) KDRAURKACDK1CHEK1CLK1
SCHEMBL3051471 0.81 AURKA (0.47) KDRAURKACDK1CHEK1
SCHEMBL3047764 0.81 KDR (0.49) KDRAURKACDK1CLK1CLK2
Hydrochloric Acid SCHEMBL3052066 0.80 AURKA (0.48) KDRAURKACDK1CLK1CLK2
SCHEMBL3042431 0.79 KDR (0.45) KDRAURKACDK1KDM4EMEN1
Hydrochloric Acid SCHEMBL3048874 0.79 AURKA (0.46) KDRAURKACDK1CLK1CLK2
Hydrochloric Acid SCHEMBL3038378 0.78 AURKA (0.43) KDRAURKACDK1PRKCAPRKCQ
SCHEMBL5333071 0.77 KDR (1.00) KDRAURKACDK1CHEK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
EP-2108642-A1 JAK INHIBITOR Kyowa Hakko Kirin Co., Ltd. (JP) 2009-10-14 EP disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1880993-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 KDR 3226/4885AURKA 2312/4885CDK1 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.